Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis
- PMID: 15014952
- DOI: 10.1007/s00403-004-0455-6
Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis
Abstract
Background: Although both interleukin-4 (IL-4) and IL-13 induce immunoglobulin E (IgE) production in vitro, the relative contribution of the two cytokines in various skin lesions of atopic dermatitis remains unclear.
Objective: We examined the relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis for IgE production.
Methods: The study group comprised 28 atopic dermatitis patients with serum IgE levels more than 2000 IU/ml. The expression levels of IL-4 mRNA and IL-13 mRNA versus that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were determined using a semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) method in samples of normal-appearing skin from seven patients, very mild lesions from eight patients, subacute lesions from ten patients and lichenified lesions from ten patients with atopic dermatitis, and in samples of normal skin from six healthy control subjects.
Results: IL-4 mRNA expression was identified in only two of the eight very mild lesions, one of the ten subacute lesions, and none of the ten lichenified lesions, whereas IL-13 mRNA expression was identified in 27 of the 28 skin lesions of atopic dermatitis. The IL-13 mRNA/GAPDH mRNA ratios (x100) in the subacute lesions (94.4+/-20.6) and lichenified lesions (71.4+/-40.4) were significantly greater than in the skin of healthy controls (13.1+/-17.7; P<0.01, P<0.05, respectively).
Conclusions: Upregulation of IL-13 mRNA in subacute and chronic lesions of atopic dermatitis along with scant expression of IL-4 mRNA suggest that IL-13 is a crucial cytokine in lesional skin.
Similar articles
-
The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.Clin Exp Allergy. 2008 Aug;38(8):1367-80. doi: 10.1111/j.1365-2222.2008.02987.x. Epub 2008 Apr 13. Clin Exp Allergy. 2008. PMID: 18489026
-
Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.J Allergy Clin Immunol. 2006 Oct;118(4):930-7. doi: 10.1016/j.jaci.2006.07.015. Epub 2006 Sep 1. J Allergy Clin Immunol. 2006. PMID: 17030248
-
Down-regulation of IL-12 by topical corticosteroids in chronic atopic dermatitis.J Allergy Clin Immunol. 2000 Nov;106(5):941-7. doi: 10.1067/mai.2000.109825. J Allergy Clin Immunol. 2000. PMID: 11080718
-
[Pathogenesis and guidelines for therapy of atopic dermatitis].Nihon Rinsho. 2001 Jun;59(6):1219-27. Nihon Rinsho. 2001. PMID: 11411139 Review. Japanese.
-
Pathophysiologic mechanisms in atopic dermatitis.Semin Cutan Med Surg. 2001 Dec;20(4):217-25. doi: 10.1053/sder.2001.29379. Semin Cutan Med Surg. 2001. PMID: 11770908 Review.
Cited by
-
A Bispecific, Tetravalent Antibody Targeting Inflammatory and Pruritogenic Pathways in Atopic Dermatitis.JID Innov. 2024 Jan 16;4(2):100258. doi: 10.1016/j.xjidi.2024.100258. eCollection 2024 Mar. JID Innov. 2024. PMID: 38375189 Free PMC article.
-
Modulation of experimental atopic dermatitis by topical application of Gami-Cheongyeul-Sodok-Eum.BMC Complement Altern Med. 2013 Nov 11;13:312. doi: 10.1186/1472-6882-13-312. BMC Complement Altern Med. 2013. PMID: 24499290 Free PMC article.
-
Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab.Dermatol Ther (Heidelb). 2023 Jul;13(7):1535-1547. doi: 10.1007/s13555-023-00947-7. Epub 2023 Jun 13. Dermatol Ther (Heidelb). 2023. PMID: 37310643 Free PMC article.
-
Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.Br J Dermatol. 2021 Mar;184(3):450-463. doi: 10.1111/bjd.19573. Epub 2021 Feb 22. Br J Dermatol. 2021. PMID: 33000503 Free PMC article. Clinical Trial.
-
Treatment of Atopic Dermatitis with Biologic Drugs.Dermatol Ther (Heidelb). 2018 Dec;8(4):527-538. doi: 10.1007/s13555-018-0258-x. Epub 2018 Sep 4. Dermatol Ther (Heidelb). 2018. PMID: 30182182 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials